Our Group in numbers
One group. Three stories.
Millions of patients served.
Novasep CDMO strengthens its innovative position in oncology
We invested €8 million in our Le Mans (Fr) site to expand our production capabilities for manufacturing ADCs. Behind every pharma project, there are high-quality services for our customers and cutting-edge drugs for millions of patients worldwide.
Combining strengths to provide existing and innovative treatments for patients
“Axplora possess a unique blend of technical expertise (chromatography and small molecule manufacturing), interpersonal skills, and a dedication to excellence that makes them an exceptional CMO. We are fortunate to have such a strong partnership with the Axplora team!”
![Partnership Paratek Axplora](https://ewec85ye45b.exactdn.com/uploads/2024/03/Paratek-logo.png?strip=all&lossy=1&webp=80&ssl=1)
“The Axplora team was very open, flexible and efficient in working through project changes.”
![Novasep CDMO, part of Axplora manufactures ADC payloads](https://ewec85ye45b.exactdn.com/uploads/2024/01/DPR55690_%40DavidPiole.jpg?strip=all&lossy=1&webp=80&ssl=1)
Francesco Liotino
Director of Business Development
“I represent the dynamic and innovative team at Axplora. As we gear up for the upcoming DCAT event, we want to extend a warm invitation to all attendees. Axplora is committed to providing solutions in the ever-evolving landscape of the pharmaceutical industry by utilizing a diverse range of global manufacturing capabilities in over three continents and connecting dedicated scientists with cutting-edge technologies. Schedule a brief conversation with us to discuss how Axplora can contribute to your success and your patient success!"
![Francesco Liotino, Director of Business Development at Axplora](https://ewec85ye45b.exactdn.com/uploads/2024/03/Francesco-Liotino.jpg?strip=all&lossy=1&webp=80&ssl=1)